AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30471229 — intervention group
Group type: EXPERIMENTAL
Intervention: High-throughput sequencing (HTS) and Transcripts per million (TPM) expression analysis
Number of subjects: 11
Study 30471229 — intervention group
Group type: EXPERIMENTAL
Intervention: RT-qPCR
Number of subjects: 11
Study 30446231 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral rotation sling
Number of subjects: 36
Study 27093778 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental oral gel
Number of subjects: 396
Study 27093778 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercially available oral rinse
Number of subjects: 396
Study 27093778 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercially available mouth spray
Number of subjects: 396
Study 27093778 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 396
Study 24305963 — intervention group
Group type: EXPERIMENTAL
Intervention: T1DM/ITx(+), with partial graft function
Number of subjects: 36
Study 24305963 — intervention group
Group type: COMPARATOR
Intervention: Controls (healthy non-diabetic individuals)
Number of subjects: 36
Study 23397817 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory cue
Number of subjects: 0
Study 23397817 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiotactile cue
Number of subjects: 0
Study 23397817 — intervention group
Group type: COMPARATOR
Intervention: Vibrotactile cue
Number of subjects: 0
Study 23397817 — intervention group
Group type: COMPARATOR
Intervention: Visual cue
Number of subjects: 0
Study 21041576 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteoarthritis self-management intervention
Number of subjects: 515
Study 21041576 — intervention group
Group type: COMPARATOR
Intervention: Health education (attention control)
Number of subjects: 515
Study 21041576 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 515
Study 18820346 — intervention group
Group type: EXPERIMENTAL
Intervention: School building footprint size
Number of subjects: 1566
Study 18820346 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of active outdoor amenities
Number of subjects: 1566
Study 15685717 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug A
Number of subjects: 0
Study 15685717 — intervention group
Group type: COMPARATOR
Intervention: Drug B
Number of subjects: 0
Study 12091578 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous stimulation of auditory and somatosensory inputs
Number of subjects: 0
Study 12091578 — intervention group
Group type: COMPARATOR
Intervention: Auditory inputs
Number of subjects: 0
Study 12091578 — intervention group
Group type: COMPARATOR
Intervention: Somatosensory inputs
Number of subjects: 0
Study 10593372 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125 mg ganirelix
Number of subjects: 45
Study 10593372 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg ganirelix
Number of subjects: 45
Study 10593372 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.50 mg ganirelix
Number of subjects: 45
Study 9206242 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganyan IV and Western medicine
Number of subjects: 60
Study 9206242 — intervention group
Group type: COMPARATOR
Intervention: Western medicine alone
Number of subjects: 60
Study 9206242 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganyan IV in mice with acute liver damage
Number of subjects: 60
Study 9206242 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal and liver damaged rats
Number of subjects: 60
Study 1831630 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily oral ondansetron treatment after a single i.v. dose prechemotherapy
Number of subjects: 0
Study 1831630 — intervention group
Group type: COMPARATOR
Intervention: Three times a day oral supplement regimen
Number of subjects: 0
Study 6984358 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolfenamic acid (200 mg) + Caffeine (100 mg)
Number of subjects: 10
Study 6984358 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolfenamic acid (200 mg) + Metoclopramide (10 mg)
Number of subjects: 10
Study 6984358 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolfenamic acid (200 mg) + Pyridoxine (300 mg)
Number of subjects: 10
Study 31484505 — intervention group
Group type: EXPERIMENTAL
Intervention: Single fraction of 20.0 Gy delivered through SBRT
Number of subjects: 126
Study 31484505 — intervention group
Group type: COMPARATOR
Intervention: Single fraction of 8.0 Gy delivered through three-dimensional conformal radiotherapy
Number of subjects: 126
Study 28396221 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice therapy (12-week protocol including vocal function exercise, hard attack, and resonance voice therapy)
Number of subjects: 19
Study 25468590 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural catheter insertion with 5 mL of isotonic sodium chloride solution containing epinephrine (1:200,000)
Number of subjects: 400
Study 25468590 — intervention group
Group type: COMPARATOR
Intervention: Epidural catheter insertion with 5 mL of isotonic sodium chloride solution (control)
Number of subjects: 400
Study 23288738 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS)
Number of subjects: 44
Study 23288738 — intervention group
Group type: COMPARATOR
Intervention: Conventional TKA
Number of subjects: 44
Study 21888678 — intervention group
Group type: EXPERIMENTAL
Intervention: Online questionnaire
Number of subjects: 2702
Study 21888678 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous mixed mode (paper questionnaire and login details sent together)
Number of subjects: 2702
Study 21888678 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential mixed mode (online followed by a paper questionnaire with reminder)
Number of subjects: 2702
Study 21888678 — intervention group
Group type: COMPARATOR
Intervention: Cost comparison
Number of subjects: 2702
Study 19480325 — intervention group
Group type: EXPERIMENTAL
Intervention: Meconium staining group
Number of subjects: 0
Study 19480325 — intervention group
Group type: COMPARATOR
Intervention: Other groups (no maternal risk factor, maternal hypertension, gestational diabetes, maternal smoking history)
Number of subjects: 0
Study 18201438 — intervention group
Group type: EXPERIMENTAL
Intervention: Olopatadine 0.6%
Number of subjects: 1240
Study 18201438 — intervention group
Group type: EXPERIMENTAL
Intervention: Olopatadine 0.4%
Number of subjects: 1240
Study 18201438 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1240
Study 15041586 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane with nitrous oxide and epidural block
Number of subjects: 40
Study 15041586 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane with nitrous oxide and epidural block
Number of subjects: 40
Study 11317098 — intervention group
Group type: EXPERIMENTAL
Intervention: UPBEAT intervention
Number of subjects: 1687
Study 11317098 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1687
Study 9246253 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg/day for 3 months, then increased to 40 mg/day for non-responders at 6 months)
Number of subjects: 140
Study 9246253 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (40 mg/day for non-responders at 6 months)
Number of subjects: 140
Study 9246253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 8280820 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral oil (2 to 8 tablespoons twice a day for two days)
Number of subjects: 36
Study 8280820 — intervention group
Group type: COMPARATOR
Intervention: Pineapple-flavoured isotonic intestinal lavage solution (20 ml/kg/h for 4 hours on two consecutive days)
Number of subjects: 36
Study 3329516 — intervention group
Group type: EXPERIMENTAL
Intervention: Traxanox sodium (120 mg)
Number of subjects: 0
Study 3329516 — intervention group
Group type: EXPERIMENTAL
Intervention: Traxanox sodium (360 mg)
Number of subjects: 0
Study 3329516 — intervention group
Group type: EXPERIMENTAL
Intervention: Traxanox sodium
Number of subjects: 0
Study 3329516 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29782218 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated judo match
Number of subjects: 17
Study 29064283 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician-guided treatment (n = 96)
Number of subjects: 191
Study 29064283 — intervention group
Group type: COMPARATOR
Intervention: Self-guided treatment (n = 95)
Number of subjects: 191
Study 27739380 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-modiolar array
Number of subjects: 64
Study 27739380 — intervention group
Group type: COMPARATOR
Intervention: Peri-modiolar array
Number of subjects: 64
Study 26075738 — intervention group
Group type: EXPERIMENTAL
Intervention: Online parent education program
Number of subjects: 182
Study 26075738 — intervention group
Group type: COMPARATOR
Intervention: No online parent education program
Number of subjects: 182
Study 23994459 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic subacromial decompression combined with radiofrequency based plasma microtenotomy (RF group, n = 40)
Number of subjects: 80
Study 23994459 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic subacromial decompression alone (ASD group, n = 40)
Number of subjects: 80
Study 20728082 — intervention group
Group type: EXPERIMENTAL
Intervention: E2 (1 mg) plus drospirenone (2 mg)
Number of subjects: 40
Study 19470807 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance-based torso weighting (BBTW)
Number of subjects: 36
Study 19470807 — intervention group
Group type: COMPARATOR
Intervention: Control group (no weights placed)
Number of subjects: 36
Study 19470807 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard weight placement of 1.5% body weight)
Number of subjects: 36
Study 17896305 — intervention group
Group type: EXPERIMENTAL
Intervention: Enrolled in the COMS PERT trial
Number of subjects: 299
Study 17896305 — intervention group
Group type: COMPARATOR
Intervention: Eligible patients not enrolled in the COMS PERT trial
Number of subjects: 299
Study 14718460 — intervention group
Group type: EXPERIMENTAL
Intervention: EBUS-guided TBNA
Number of subjects: 200
Study 14718460 — intervention group
Group type: COMPARATOR
Intervention: Conventional TBNA
Number of subjects: 200
Study 11573708 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable cardiac defibrillators
Number of subjects: 997
Study 11573708 — intervention group
Group type: COMPARATOR
Intervention: Antiarrhythmic drugs
Number of subjects: 997
Study 11573708 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehospitalization for any reason
Number of subjects: 997
Study 11573708 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehospitalization for a cardiac problem
Number of subjects: 997
Study 11573708 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehospitalization for a noncardiac problem
Number of subjects: 997
Study 11573708 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehospitalization for an acute coronary syndrome
Number of subjects: 997
Study 11573708 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehospitalization for a cardiac procedure
Number of subjects: 997
Study 9468008 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive dietary counselling (sodium-reduced <100 mmol/24h, potassium-enriched >75 mmol/24h, weight-reducing diet)
Number of subjects: 42
Study 9468008 — intervention group
Group type: COMPARATOR
Intervention: Chlorthalidone 25 mg/day
Number of subjects: 42
Study 7851167 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride
Number of subjects: 14
Study 7851167 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 2151274 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoladex, 3.6 mg depot, plus flutamide, 250 mg t.i.d.
Number of subjects: 0
Study 2151274 — intervention group
Group type: COMPARATOR
Intervention: Bilateral orchidectomy
Number of subjects: 0
Study 2151274 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 0
Study 356792 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide aerosol, 800 microgram daily
Number of subjects: 60
Study 356792 — intervention group
Group type: COMPARATOR
Intervention: Aerosol placebo
Number of subjects: 60
Study 31335458 — intervention group
Group type: EXPERIMENTAL
Intervention: eMoCA
Number of subjects: 40
Study 31335458 — intervention group
Group type: COMPARATOR
Intervention: paper MoCA
Number of subjects: 40
Study 28039321 — intervention group
Group type: EXPERIMENTAL
Intervention: Cangrelor
Number of subjects: 1270
Study 28039321 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 1270
Study 26124351 — intervention group
Group type: EXPERIMENTAL
Intervention: E-CMF (epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil)
Number of subjects: 298
Study 26124351 — intervention group
Group type: EXPERIMENTAL
Intervention: E-CMF
Number of subjects: 298
Study 26124351 — intervention group
Group type: COMPARATOR
Intervention: E-T-CMF (E-CMF with paclitaxel)
Number of subjects: 298
Study 26574828 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal clips used to fix proximal segments of stents during the perioperative period.
Number of subjects: 83
Study 26574828 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group).
Number of subjects: 83
Study 23241048 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 300, 450 and 600 mg/day
Number of subjects: 0
Study 23241048 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20937978 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompt revascularization
Number of subjects: 2368
Study 20937978 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 2368
Study 20937978 — intervention group
Group type: COMPARATOR
Intervention: Insulin provision
Number of subjects: 2368
Study 18184631 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg elemental zinc per day
Number of subjects: 179
Study 18184631 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 179
Study 17015057 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous midazolam (0.25 mg/kg)
Number of subjects: 130
Study 17015057 — intervention group
Group type: EXPERIMENTAL
Intervention: Low midazolam clearance (<9.5 mL x kg(‐1) x min(‐1))
Number of subjects: 130
Study 17015057 — intervention group
Group type: COMPARATOR
Intervention: Control patients (non-ONFH)
Number of subjects: 130
Study 17015057 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-related ONFH patients
Number of subjects: 130
Study 14653286 — intervention group
Group type: EXPERIMENTAL
Intervention: Halogen curing light in standard mode (HS)
Number of subjects: 45
Study 14653286 — intervention group
Group type: EXPERIMENTAL
Intervention: Halogen curing light in exponential mode (HE)
Number of subjects: 45
Study 14653286 — intervention group
Group type: EXPERIMENTAL
Intervention: LED curing light in standard mode (LS)
Number of subjects: 45
Study 14653286 — intervention group
Group type: EXPERIMENTAL
Intervention: LED curing light in exponential mode (LE)
Number of subjects: 45
Study 14653286 — intervention group
Group type: COMPARATOR
Intervention: Control group (specimens stored in air)
Number of subjects: 45
Study 11078841 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose radiotherapy (20 Gy of 6-MV photons to the macula of the affected eye)
Number of subjects: 101
Study 11078841 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 101
Study 9021649 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrodermal responses (EDR)
Number of subjects: 6
Study 9021649 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin resistance and skin conductance ohmic perturbation duration indices
Number of subjects: 6
Study 9021649 — intervention group
Group type: EXPERIMENTAL
Intervention: Conductance amplitude
Number of subjects: 6
Study 9021649 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin potential responses
Number of subjects: 6
Study 9021649 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin temperature, skin blood flow, and instantaneous respiratory frequency
Number of subjects: 6
Study 9021649 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-oscillatory duration index values
Number of subjects: 6
Study 9021649 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin temperature
Number of subjects: 6
Study 9021649 — intervention group
Group type: EXPERIMENTAL
Intervention: Instantaneous respiratory frequency perturbation duration index
Number of subjects: 6
Study 7514156 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 24
Study 7514156 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 3371094 — intervention group
Group type: COMPARATOR
Intervention: Oxygen delivered by nasal prongs (3 L/min)
Number of subjects: 16
Study 3371094 — intervention group
Group type: COMPARATOR
Intervention: Oxygen delivered by economizer (3 L/min)
Number of subjects: 16
Study 3371094 — intervention group
Group type: COMPARATOR
Intervention: Comparison between economizer and nasal prongs in COPD patients
Number of subjects: 16
Study 30021626 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa-based products (mean intake 618.7 mg/day)
Number of subjects: 226
Study 30021626 — intervention group
Group type: EXPERIMENTAL
Intervention: Berries
Number of subjects: 226
Study 30021626 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea
Number of subjects: 226
Study 30021626 — intervention group
Group type: EXPERIMENTAL
Intervention: Black tea
Number of subjects: 226
Study 30021626 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine (mean intake 123.7 mg/day)
Number of subjects: 226
Study 26744107 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant interferon alfa‐2b (IFN) therapy
Number of subjects: 0
Study 26744107 — intervention group
Group type: EXPERIMENTAL
Intervention: Completion lymph node dissection (CLND) with IFN
Number of subjects: 0
Study 26744107 — intervention group
Group type: EXPERIMENTAL
Intervention: Completion lymph node dissection (CLND) without IFN
Number of subjects: 0
Study 26744107 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB) alone
Number of subjects: 0
Study 26744107 — intervention group
Group type: COMPARATOR
Intervention: Observation (control group)
Number of subjects: 0
Study 25515708 — intervention group
Group type: EXPERIMENTAL
Intervention: Long pulsed 1064 nm Nd:YAG laser (LPND) treatment with three passes at a spot size of 12 mm, 20-24 J/cm² fluence, 12 ms width, and frequency of 2 Hz, for three sessions every four weeks
Number of subjects: 20
Study 25515708 — intervention group
Group type: COMPARATOR
Intervention: Control side (untreated)
Number of subjects: 20
Study 23064597 — intervention group
Group type: EXPERIMENTAL
Intervention: FSBB‐MRA in patients with stroke
Number of subjects: 15
Study 23064597 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 15
Study 20307245 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery plus adjuvant 5-fluorouracil (5-FU)-based chemotherapy
Number of subjects: 1006
Study 20307245 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 1006
Study 20307245 — intervention group
Group type: EXPERIMENTAL
Intervention: MMR protein negative tumors
Number of subjects: 1006
Study 20307245 — intervention group
Group type: EXPERIMENTAL
Intervention: MMR protein positive tumors
Number of subjects: 1006
Study 18250501 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral rhEPO 400 U/kg, three times/week, plus FeSO4 3-6 mg/Kg/day (Study group)
Number of subjects: 16
Study 18250501 — intervention group
Group type: COMPARATOR
Intervention: FeSO4 only (Control group)
Number of subjects: 16
Study 16368469 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Therapy (HT) - 1mg estradiol + 0.5 mg norethisterone acetate
Number of subjects: 50
Study 16368469 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 50
Study 12797703 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline 7.35 mg/kg/day intravenously combined with anti-tuberculosis agents (isoniazid, rifampicin, ethambutol, pyrazinamide)
Number of subjects: 20
Study 11156459 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal compliance measurement using a latex rectal balloon filled with water at a rate of 60 ml per minute.
Number of subjects: 974
Study 11156459 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal toleration volume measurement.
Number of subjects: 974
Study 8979383 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-discrepancy
Number of subjects: 47
Study 8979383 — intervention group
Group type: EXPERIMENTAL
Intervention: Regulatory focus
Number of subjects: 47
Study 8979383 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlates of regulatory focus
Number of subjects: 47
Study 7930085 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-admission programme for psychological preparation (videotape, tour, hospital play)
Number of subjects: 75
Study 7930085 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention group
Number of subjects: 75
Study 3294976 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled albuterol (2 puffs)
Number of subjects: 13
Study 3294976 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled metaproterenol (2 puffs)
Number of subjects: 13
Study 3294976 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled albuterol (1 puff)
Number of subjects: 13
Study 3294976 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled metaproterenol (1 puff)
Number of subjects: 13
Study 3294976 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 29519283 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment group (lateral position ventilation + vibration sputum drainage)
Number of subjects: 196
Study 29519283 — intervention group
Group type: COMPARATOR
Intervention: Simple ventilation group (bilateral discontinuous alternative lateral position ventilation)
Number of subjects: 196
Study 27614450 — intervention group
Group type: EXPERIMENTAL
Intervention: Tangyiping Granules (TYP) 10 g twice daily for 12 weeks
Number of subjects: 127
Study 25360512 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemon balm preparation in a beverage
Number of subjects: 0
Study 25360512 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemon balm preparation in yoghurt
Number of subjects: 0
Study 25360512 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study 23220316 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1: treated per manufacturers' instructions
Number of subjects: 60